A carregar...

Efficacy and Safety of Degludec Compared to Glargine 300 Units/mL in Insulin-Experienced Patients With Type 2 Diabetes: Trial Protocol Amendment (NCT03078478)

BACKGROUND: A head-to-head trial (NCT03078478) between insulin degludec and insulin glargine U300 with the primary objective of comparing the risk of hypoglycemia is being conducted. During trial conduct, safety concerns related to the glycemic data collection system led to a postinitiation protocol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Diabetes Sci Technol
Main Authors: Philis-Tsimikas, Athena, Stratton, Irene, Nørgård Troelsen, Lone, Anker Bak, Britta, Leiter, Lawrence A.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501520/
https://ncbi.nlm.nih.gov/pubmed/30974986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296819841585
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!